← The Wire
IKTNasdaq
Inhibikase Therapeutics, Inc.
Biological Products, (No Diagnostic Substances) · DE · CIK 1750149
Develops protein kinase inhibitor therapeutics for cardiopulmonary diseases and infections
red 8-K · 90d
$220M
Market cap
$1.93
Last close
+1.1%
1D
+4.9%
5D
514K
Volume
Price · last 39 sessions-0.5%
May 4L $1.57 · H $2.06Jun 29
142
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end
8-KExecutive Change · Bylaw AmendmentJun 29, 202610-Q10-QMay 12, 20268-KResults of OperationsMay 12, 2026DEFA14ADEFA14AApr 30, 2026DEF 14ADEF 14AApr 30, 20268-KReg FD DisclosureApr 7, 202610-K10-KMar 26, 20268-KResults of OperationsMar 26, 20268-KCompany UpdateDec 19, 2025424B5424B5Dec 19, 20258-KMaterial Agreement · Company UpdateNov 21, 2025424B5424B5Nov 21, 2025424B5424B5Nov 20, 20258-KCompany UpdateNov 20, 202510-Q10-QNov 14, 20258-KResults of OperationsNov 14, 202510-Q10-QAug 14, 20258-KResults of Operations · Reg FD DisclosureAug 14, 20258-KShareholder VoteJun 30, 2025DEFA14ADEFA14AJun 12, 202510-Q10-QMay 14, 20258-KResults of OperationsMay 14, 2025DEFA14ADEFA14AMay 12, 2025DEF 14ADEF 14AMay 12, 202510-K/A10-K/AApr 25, 20258-KExecutive Change · Reg FD DisclosureApr 14, 202510-K10-KMar 27, 20258-KResults of OperationsMar 27, 20258-KExecutive Change · Material AgreementFeb 24, 20258-KExecutive Change · Reg FD DisclosureFeb 18, 20258-KCompany UpdateJan 29, 20258-KBylaw Amendment · Shareholder VoteJan 6, 20258-KAgreement TerminatedDec 5, 2024DEF 14ADEF 14ANov 18, 2024SC 13GSC 13GNov 14, 202410-Q10-QNov 14, 2024SC 13GSC 13GOct 28, 2024SC 13GSCHEDULE 13GOct 28, 2024SC 13GSC 13GOct 25, 2024SC 13GSC 13GOct 22, 20248-KExecutive Change · Material AgreementOct 22, 2024SC 13GSC 13GOct 17, 2024SC 13GSC 13GOct 17, 20248-KExecutive Change · Material AgreementOct 10, 2024SC 13GINHIBIKASE THERAPEUTICS, INC.Oct 10, 20248-KReg FD DisclosureOct 9, 202410-Q10-QAug 14, 20248-KShareholder VoteAug 6, 2024DEFA14ADEFA14AJun 21, 2024DEF 14ADEF 14AJun 20, 2024S-1S-1Jun 18, 20248-KShareholder VoteJun 10, 2024424B5424B5May 22, 20248-KMaterial Agreement · Equity IssuanceMay 20, 2024424B5424B5May 20, 202410-Q10-QMay 15, 2024S-1/AS-1/AMay 9, 2024S-1/AS-1/AMay 9, 20248-KReg FD Disclosure · Company UpdateApr 30, 2024S-1/AS-1/AApr 29, 2024DEFA14ADEFA14AApr 26, 2024DEF 14ADEF 14AApr 26, 2024S-1/AS-1/AApr 25, 2024S-1S-1Apr 19, 20248-KReg FD DisclosureApr 19, 20248-K/AExecutive ChangeApr 2, 202410-K10-KMar 27, 20248-KCompany UpdateFeb 7, 2024424B5424B5Feb 1, 20248-KMaterial AgreementFeb 1, 20248-KExecutive ChangeJan 16, 202410-Q10-QNov 14, 202310-K/A10-K/AOct 16, 20238-KReg FD DisclosureSep 20, 202310-Q10-QAug 14, 20238-KCompany UpdateJul 17, 20238-KSecurity-Holder Rights · Bylaw AmendmentJun 29, 20238-KShareholder VoteJun 28, 202310-Q10-QMay 15, 2023DEFA14ADEFA14AMay 12, 2023
Insider Activity
In the 90 days to Nov 21, 2025: 1 insider bought $3.0M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 21, 2025 | Sands Frank M.TenPercentOwner | Buy | 2,068,965 | $1.45 | $3.0M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance